ABI-200

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameABI-200
Drug Alias Namepeptidoglycan hydrolase fusion protein (Adrem Biotech)ABI-200
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdrem Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnited States Department Of Agriculture (Usda)Adrem Biotech
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A